Receptor Nomenclature Guidelines

Michael Williams1

1 Abbott Laboratories, Abbott Park, Illinois
Publication Name:  Current Protocols in Pharmacology
Unit Number:  Appendix 1B
DOI:  10.1002/0471141755.pha01bs06
Online Posting Date:  May, 2001
GO TO THE FULL TEXT: PDF or HTML at Wiley Online Library

Abstract

Receptors are typically characterized via two distinct approaches: (1) the identification and pharmacological characterization of a receptor‐mediated response using classical pharmacological and/or radioligand approaches in tissues and animal models using selective agonist and antagonist ligands, and; (2) the cloning and expression of proteins with structural homology to known receptors, the function of which is subsequently established by studying the structure activity relationship (SAR) of receptor‐mediated responses. An additional means to characterize receptors proceeded, and evolved, with the structural approach, namely classification in terms of signal transduction mechanisms. The International Union of Pharmacology (IUPHAR) created guidelines and selected working groups for each receptor family to establish a common nomenclature system. Reports from those groups that have reached some degree of consensus have been summarized in this appendix.

     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Table of Contents

  • Literature Cited
  • Tables
     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Materials

GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Figures

Videos

Literature Cited

Literature Cited
   Alexander, S.P.H. and Peters, J.A. 1999. TiPS Receptor and Ion Channel Nomenclature Supplement, 10th ed. Elsevier Trends Journals, Cambridge, U.K.
   Anand‐Srivastava, M.B. and Trachte, G.J. 1993. Atrial naturetic factor receptors and signal transduction mechanisms. Pharmacol. Rev. 45:455‐497.
   Baggiolini, M., Dewald, B., and Moser, B. 1997. Human chemokines: An update. Ann. Rev. Immunol. 15:675‐705.
   Barberis, C., Mouillac, B., and Durroux, T. 1998. Structrual base o f vasopressin/oxytocin receptor function. J. Endocrinol. 156:223‐229.
   Bartfai, T. 1995. Galanin: A neuropeptide with important central nervous system actions. In Psychopharmacology: Fourth Generation of Progress (F.E. Bloom and D.E. Kupfer, eds.) pp. 563‐571. Raven Press, New York.
   Betz, H. 1991. Glycine receptors: Heterogeneous and widespread distribution in the mammalian brain. Trends Neurosci. 14:458‐461.
   Boess, F.G. and Martin, I.L. 1994. Molecular biology of 5HT receptors. Neuropharmacology 33:275‐317.
   Bowery, N.G. 1993. GABAB receptor pharmacology. Ann. Rev. Pharmacol. Toxicol. 33:109‐147.
   Blomquist, A.F. and Herzog, H. 1997. Y‐receptor subtypes—How many more? Trends Neurosci. 20:294‐298.
   Brass, L.F. and Molino, M. 1997. Protease‐activated G protein coupled receptors on human platelets and endothelial cells. Thromb. Hemost. 78:234‐241.
   Brooks, C.D.W. and Summers, J.B. 1996. Modulators of leukotriene biosynthesis and receptor activation. J. Med. Chem. 39:2629‐2654.
   Buck, S.H. (ed.) 1994. The Tachykinin Receptors. Humana Press, Totowa, N.J.
   Caterina, M.J., Schumacher, M.A., Tominaga, M., Rosen, T.A., Levin, J., and Julius, D. 1997. The capsaicin receptor: A heat‐activated ion channel in the pain pathway. Nature 389:816‐824.
   Caterina, M.J., Rosen, T.A., Tominaga, M., Brake, A.J., and Julius, D. 1999. A capsaicin‐receptor homologue with a high threshold for noxious heat. Nature 398:436‐441.
   Catterall, W.A. 1995. Structure and function of voltage gated ion channels. Ann. Rev. Biochem. 64:493‐531.
   Chao, W. and Olsen, M.S. 1993. Platelet activating factor: Receptors and signal transduction. Biochem. J. 292:617‐629.
   Coleman, R.A., Smith, W.L., and Narumiya, S. 1994. Classification of prostanoid receptors. Pharmacol. Rev. 46:205‐229.
   Colquhoun, D. 1998. Binding, gating, affinity and efficacy: The interpretation of structure‐activity relationships for agonists and the effects of mutating receptors. Br. J. Pharmacol. 125:923‐947.
   Cone, R.D., Lu, D., and Chen, W. 1996. The melanocortin receptors: Agonists, antagonists, and the hormonal control of pigmentation. Recent Prog. Horm. Res. 51:287‐318.
   Conn, P.J. and Pin, J.‐P. 1998. Pharmacology and functions of metabotropic glutamate receptors. Ann. Rev. Pharmacol. Toxicol. 37:205‐237.
   Costa, E. 1998. From GABAA receptor diversity emerges a unified version of GABAergic inhibition. Ann. Rev. Pharmacol. Toxicol. 38:321‐350.
   Dhawan, B.N., Raghubir, R., and Hamon, M. 1998. Opioid receptors. In The IUPHAR Compendium of Receptor Characterization and Classification (IUPHAR, ed.) pp. 218‐226. IUPHAR Media.
   Davenport, A.P. and Masaski, T. 1998. Endothelin Receptors. In The IUPHAR Compendium of Receptor Characterization and Classification (IUPHAR, ed.) pp. 152‐159. IUPHAR Media.
   De Souza, E.B., Grigoriadis, D.E., and Vale, W.W. 1998. Corticotropin Releasing Factor Receptors. In The IUPHAR Compendium of Receptor Characterization and Classification (IUPHAR, ed.) pp. 134‐140. IUPHAR Media.
   Edwards, G. and Weston, A.H. 1997. Recent advances in potassium channel modulation. Prog. Drug Res. 49:93‐121.
   Eglen, R.M. and Watson, N. 1996. Selective muscarinic receptor agonists and antagonists. Pharmacol. Toxicol. 78:59‐68.
   Foord, S.M. and Marshall, F.H. 1999. RAMPs: Accessory proteins for seven transmembrane domain receptors. Trends Pharmacol. Sci. 20:184‐187.
   Gershengorn, M.C. and Osman, R. 1998. Molecular and cellular biology of thyrotropin‐releasing hormone (TRH) receptors. Physiol. Rev. 76:175‐191.
   Goetzl, E.J. and An, S. 1998. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1‐phosphate. FASEB J. 12:1589‐1598.
   Green, J.P. 1987. Pharmacological receptors: The need for a compendium of classification, nomenclature and structure. Trends Pharmacol. Sci. 8:90‐94.
   Green, T., Heinemann, S.F., and Gusella, J.F. 1998. Molecular neurobiology and genetics: Investigation of neural function and dysfunction. Neuron 20:427‐444.
   Greindling, K.K., Lassegue, B., and Alexander, W. 1996. Angiotensin receptors and their therapeutic implications. Ann. Rev. Pharmacol. Toxicol. 36:281‐306.
   Harmar, A.J., Arimura, A., Gozes, I., Journot, L., Laburthe, M., Pisegna, J.R., Rawlings, S.R., Robberecht, P., Said, S.I., Sreedharan, S.P., et al. 1998. VIP and PACAP receptors. In The IUPHAR Compendium of Receptor Characterization and Classification (IUPHAR, ed.) pp. 256‐265. IUPHAR Media.
   Heible, J.P., Bondinelli, W.E., and Ruffolo, R.R. Jr. 1995. Alpha and beta adrenoceptors: From the gene to the clinic. Part I. J. Med. Chem. 38:3415‐3444.
   Holladay, M.W., Dart, M.J., and Lynch, J.K. 1997. Neuronal nicotinic cholinergic receptors as targets for drug discovery. J. Med. Chem. 40:4169‐4194.
   Hollenberg, M.D. 1996. Proteinase‐mediated signalling: New paradigms for cell regulation and drug development. Trends Pharmacol. Sci. 17:3‐7.
   Hollman, M. and Heinemann, S. 1994. Cloned glutamate receptors. Ann. Rev. Neurosci. 17:31‐108.
   Humphrey, P.P.A. and Barnard, E.A. 1998. International Union of Pharmacology. XIX. The IUPHAR receptor code: A proposal for an alphanumeric classification system. Pharmacol. Rev. 50:271‐277.
   International Union of Pharmacology (IUPHAR; ed.) 1998. The IUPHAR Compendium of Receptor Characterization and Classification, pp. 21‐30. IUPHAR Media.
   Jentsch, T.J. and Gunther, W. 1997. Chloride channels: An emerging molecular picture. BioEssays 19:117‐126.
   Joseph, S.K. 1990. The inositol trisphosphate receptor family. Cell Signal 8:1‐7.
   Kaplan, D.R. and Miller, F.D. 1997. Signal transduction by the neurotrophin receptors. Curr. Opin. Cell Biol. 9:213‐221.
   Kenakin, T. 1996. The classification of seven transmembrane receptors in recombinant expression systems. Pharmacol. Rev. 48:413‐465.
   Kliewer, S.A, Lehmann, J.M. and Willson, T.M. 1999. Orphan nuclear receptors: Shifting endocrinology into reverse. Science 285:757‐760.
   Kroog, G.S., Jensen, R.T., and Battey, J.F. 1995. Mammalian bombesin receptors. Med. Res. Rev. 15:389‐417.
   Leurs, R., Smit, M.J., and Timmerman, H. 1995. Molecular pharmacological aspects of histamine receptors. Pharmacol. Ther. 66:413‐463.
   Levitzki, A. and Gazit, A. 1995. Tyrosine kinase inhibition: An approach to drug development. Science 257:1782‐1788.
   Lovenberg, T.W., Roland, B.L., Wilson, S.J., Jian, X., Pyati, J., Huvar, A., Jackson, M.R., and Erlander, M.G. 1999. Cloning and functional expression of the human histamine H3 receptor. Mol. Pharmacol. 55:1101‐1107.
   Meissner, G. 1994. Ryanodine receptor/Ca2+ release channels and their regulation by physiological effectors. Ann. Rev. Physiol. 56:485‐508.
   Metters, K.M. 1995. Leukotriene receptors. J. Lipid Mediat. Cell Signal. 12:4113‐4127.
   Missale, C., Caron, M.C., and Jaber, M. 1998. Dopamine receptors: From structure to function. Physiol. Rev. 78:189‐225.
   Murphy, P.M., Charo, I.F., Hebert, C.A., Horuk, R., Miller, L.H., Power, C.A., and Oppenheim, J.J. 1998. Chemokine Receptors. In The IUPHAR Compendium of Receptor Characterization and Classification (IUPHAR, ed.) pp. 103‐126. IUPHAR Media.
   Nomenclature Working Party. 1998. Nomenclature Guidelines for Authors. Br. J. Pharmacol. 123:11‐14.
   Perez‐Reyes, E. and Schnieder, T. 1994. Calcium channels structure, function and classification. Drug Dev. Res. 33:295‐318.
   Pertwee, R.G. 1997. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol. Ther. 74:129‐180.
   Poyner, D.R. 1992. Pharmacological of receptors for calcitonin gene related peptide and amylin. Pharmacol. Ther. 56:23‐51.
   Ralevic, V. and Burnstock, G. 1998. Receptors for purines and pyrimidines. Pharmacol. Rev. 50:413‐492.
   Regoli, D., Geppetti, P., Hess, J.F., Marceau, F., Muler‐ Esterl, W., and Schoelkens, B.A. 1998. Bradykinin Receptors. In The IUPHAR Compendium of Receptor Characterization and Classification (IUPHAR, ed.) pp. 87‐93. IUPHAR Media.
   Regunathan, S. and Reis, D.J. 1996. Imidazoline receptors and their endogenous ligands. Ann. Rev. Pharmacol. Toxicol. 36:511‐544.
   Reppert, S.M., Weaver, D.R., and Godson, C. 1996. Melatonin receptors step into the light: Cloning and classification of subtypes. Trends Pharmacol. Sci. 17:100‐102.
   Roques, B.P. and Noble, F. 1998. Cholecystokinin Receptors. In The IUPHAR Compendium of Receptor Characterization and Classification (IUPHAR, ed.) pp. 127‐133. IUPHAR Media.
   Rostene, W. and Alexander, M.J. 1997. Neurotensin and neuroendocrine regulation. Frontiers Neuroendocrinol. 18:115‐173.
   Satoh, M. and Minami, M. 1995. Molecular pharmacology of opioid receptors. Pharmacol. Ther. 68:343‐364.
   Schindler, M., Humphrey, P.P.A., and Emson, P.C. 1996. Somatostatin receptors in the central nervous system. Prog. Neurobiol. 50:9‐47.
   Simoni, M.J.G. and Nieschlag, E. 1997. The follicle stimulating hormone receptor: Biochemistry, molecular biology, physiology and pathophysiology. Endocrine Rev. 18:739‐773.
   Sutko, J.L. and Airey, J.A. 1996. Ryanodine Ca2+ release channels: Does diversity in form equal diversity in function?. Physiol. Rev. 76:1027‐1071.
   Szallasi, A. and Blumberg, P.M. 1996. Vanilloid receptors: New insights enhance potential as a therapeutic target. Pain 68:195‐208.
   Tsai, M.‐J. and O'Malley, B.W. 1994. Molecular mechanism of action of steroid/thyroid receptor superfamily members. Ann. Rev. Biochem. 63:451‐486.
   Vanhoutte, P., Humphrey, P.P.A., and Spedding, M. 1996. International Union of Pharmacology. X. Pharmacology recommendations for nomenclature of new receptor subtypes. Pharmacol. Rev. 48:1‐2.
   Walker, D. and DeWaard, M. 1998. Subunit interaction sites in voltage‐dependent calcium channels. Trends Neurosci. 21:148‐154.
   Wank, S.A. 1995. Cholecystokinin receptors. Am. J. Physiol. 269:G628‐G646.
   Watling, K.J. 1998. The RBI Handbook of Receptor Classification and Signal Transduction, 3rd ed. RBI, Natick, Mass.
   Wess, J. 1996. Molecular biology of muscarinic acetylcholine receptors. Crit. Rev. Neurobiol. 10:69‐99.
   White, J.H., Wise, A., Main, M.J., Green, A., Fraser, N.J., Disney, G.H., Barnes, A.A., Emson, P., Foord, S.M., and Marshall, F.H. 1998. Heterodimerization is required for the formation of a functional GABAB receptor. Nature 396:679‐682.
   Williams, M. 1987. Receptor Nomenclature. How, What and When?. Trends Pharmacol. Sci. 8:251‐252.
   Wilson, S., Bergsma, D.J., Chambers, J.K., Muir, A.I., Fantom, K.G.M., Ellis, C., Murdock, P.R., Herrity, N.C., and Stadel, J.M. 1998. Orphan‐G‐protein‐coupled receptors: The next generation of drug targets?. Br. J. Pharmacol. 125:1387‐1392.
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library